KPS Acquires 45% Stake in Bio Company BigThink
[Asia Economy Reporter Minji Lee] KPS announced on the 6th that it acquired 2 million shares of Bigsync, a biopharmaceutical development company, for 6 billion KRW. This corresponds to 19.8% of its equity capital.
Hot Picks Today
Samsung Electronics Introduces New "Special Performance Bonus" for Semiconductors, Paid Entirely in Company Shares
- "Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- Hyundai Mobis, Key Supplier for Hyundai’s Atlas, Target Price Raised [Click eStock]
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
After the acquisition, KPS's stake in Bigsync stands at 45.35%. The company stated, "We acquired the shares to support operating funds of other corporations and to maximize corporate value in order to enter the bio business."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
